Home > Back to Publisher > Report Information

Proteomics: Technologies and Global Markets

BCC Research
June 1, 2009
226 Pages - SKU: WA2305184

Abstract Table of Contents Related Reports

Countries covered: Global

REPORT HIGHLIGHTS

The global market for proteomics is expected to increase from $6.7 billion in 2008 to an estimated $7.9 billion in 2009 and $19.4 billion in 2014, for a compound annual growth rate (CAGR) of 19.7%.

Proteomics equipment was valued at $4.1 billion in 2008 and an estimated $4.8 billion in 2009. This is expected to increase to $13.0 billion in 2014, for a CAGR of 22%.

Proteomics technologies were worth $1.3 billion in 2008 and an estimated $1.5 billion in 2009. This segment is expected to increase at a CAGR of 13.9% to reach $2.9 billion in 2014.

CHAPTER ONE: INTRODUCTION: STUDY GOALS AND OBJECTIVES; REASONS FOR DOING THE STUDY; SCOPE OF REPORT; INTENDED AUDIENCE; INFORMATION SOURCES; ANALYST CREDENTIALS; RELATED BCC REPORTS; BCC ONLINE SERVICES; DISCLAIMER
CHAPTER TWO: SUMMARY
CHAPTER THREE: MARKET OVERVIEW: DEFINING THE PROTEOMICS MARKET; TECHNOLOGICAL INNOVATION BOOSTING PROTEOMICS EQUIPMENT MARKET; EMERGENCE OF PROTEOMICS SERVICES MARKET; KEY FACTORS INFLUENCING THE PROTEOMICS MARKET; PROTEOMICS MARKET LED BY U.S. CENTRIC PLAYERS; EQUIPMENT PROVIDERS ARE KEY EARNERS AND DRUG DISCOVERY COMPANIES ARE KEY INVESTORS; MARKET DRIVERS; DRAWBACKS OF GENOMICS IGNITING THE GROWTH OF PROTEOMICS:; NEED TO IMPROVE THE SPEED AND EFFICIENCY OF DRUG DISCOVERY; PROTEOMICS LEADS TO INCREASE IN R&D PRODUCTIVITY; CONTINUED DEVELOPMENT OF TECHNOLOGIES; CAPABILITY OF PROTEOMICS IN DEVELOPING PERSONALIZED THERAPY; LOWER SAMPLE REQUIREMENTS LEADS TO COST EFFECTIVENESS; IDENTIFICATION OF 3-D STRUCTURE OF PROTEINS AIDS IN DRUG DESIGN; MULTI-TASKING PLATFORMS CONFIRM THE ROLE OF TARGET PROTEINS IN DISEASE; MARKET INHIBITORS; MASSIVE DIVERSIFIED DATA LEADS TO THE NEED OF STRUCTURING A STANDARD FORM; STRUCTURING OF PROTEINS REQUIRES EXPENSIVE TOOLS AND MACHINES LEADING TO LOWER ADOPTION RATES; NEED FOR WELL-QUALIFIED RESEARCHERS AND MANDATORY TRAINING, INCREASES THE COST FACTOR; COST AND REIMBURSEMENT COMPLEXITIES EMERGING AS MAJOR HINDRANCES; NEED FOR MORE SOPHISTICATED TOOLS FOR HIGHEREND ANALYSIS; RIGID STRUCTURE OF PROTEINS COMPLICATE FURTHER RESEARCH; LACK OF TECHNOLOGIES TO SPEED UP VALIDATION PROCESS; OPPORTUNITIES; BIO MARKER IDENTIFICATION OPENING OPPORTUNITIES; COMBINATION OF PROTEOMICS AND METAOLOME STUDIES COULD LEAD TO EFFECTIVE PERSONALIZED MEDICINES; THE INTEREST OF PROTEOMICS PRODUCTS AND SERVICE SUPPLIERS ENSURES GROWTH OF PROTEOMICS; PROTEOMICS DATA ANALYSIS LEADS TO MORE AND IMPROVED DRUGS
CHAPTER FOUR: GLOBAL PROTEOMICS EQUIPMENT MARKET: PROTEIN CHIPS AND MICROARRAYS; TOP PLAYERS; BIOCHIPS/SLIDES; Market Drivers; Measurement Done by Protein Biochips is Much Easier than Other Traditional Methods of Research; Protein Biochips Take Less Time for Analysis, which Makes Them Favorites for Protein Expression Profiling; Presence of Competitive Methods for Protein Identification Acts as an Obstacle for Protein Biochips; MICROARRAYS; Market Drivers; Multi Processing Capacity of Microarrays Driving its Adoption Rate in Proteomics; Microarrays Provide Complete Protein Profiling Leading to its Utilization in Basic Research; Minimal Use of Materials Makes Microarrays an Inexpensive Technology; Use of Recombinant Methods Establishes Direct Connectivity between DNA Sequences; Growth of Pharmaceutical Industry is Leading to the Growth of the Microarray Market; SCANNERS; INTEGRATED SYSTEMS; PROTEIN ANALYSIS SYSTEM/PROTEOMICS SYSTEM; PROTEIN-PROTEIN INTERACTION/AFFINITY CHARACTERIZATION SYSTEMS; MEMBRANE PROTEIN ANALYSIS SYSTEMS; PROTEIN INTERCATION MONITORING SYSTEMS—REAGENTS; PROTEIN FRACTIONATION SYSTEMS; SPR SYSTEMS; 2-DE MARKET; MARKET DRIVERS; Enhanced Features of This System Lead to Higher Throughput; Collection of Substantial Amount of Information through Image Analysis and Data Mining Solutions; Investments by Researchers Leading To the Growth of This System; This System Consumes Time and is Labor Intensive; RECENT DEVELOPMENTS; 2-DGE SYSTEMS; Market Drivers; Growth of 2-DGE Market Ignites the Growth for 2-DGE Systems; Use of 2-DGE in Medical Applications Escalating Demand for Proteomics Systems:; 2-DE Systems Complement Other Techniques, Which Adds to Their Application Portfolio:; Difficulties Associated with 2-D Gels Restrict 2-DE; Systems from Being Used at Full Potential; ISOELECTRIC FOCUSING SYSTEMS (FRACTIONATORS, GELS, AND STRIPS); Market Drivers; Multi-Metric Composition Leading to High Resolution and Purity of Samples; Negligible Interactions with Metal Ions; User Friendly; Others Factors Driving the Market; 2-DE CELLS; 2-D PROTEIN MW MARKERS; MF CHIP TECHNOLOGY/MF SYSTEMS; MARKET DRIVERS; A Tool for Analyzing the Drug’s Effectiveness, Pharmacological Profiling, and Toxicity Testing; Significant Contribution to the Field of Diagnosis and Treatment; Helpful In the Detection of Various Non-Communicable Diseases; A Significant Role in the Field of Quality Control; Minimum Wastage, Low Reagents Costs, and Less Requirement of the Sample Volume for Diagnostics; Others; MARKET INHIBITORS; LOC is a Novel Technology that Requires Further Refinement; Precision Engineering Still Remain Comparatively Sophisticated; TOP PLAYERS; MF CHIPS AND CHIPS-BASED IMMUNOASSAYS; MARKET DRIVERS; Cost-Effective Complex Analysis System Can Be Developed on a MF Chip; MF Chip Acts as an Essential Tool for MS; Complete Automation in a Single Device Leads to Reduction in Accidental Loss of Reagents; Microchips Enable Greater Speed and Higher Quality of Output; The Minimal Requirement of Samples Results in Cost Reduction; MF Chip Technology Unable to Mix Fluids on the Chips in an Effective Manner, Making Them Less Favorable for Analysis of Complex Fluids; HTS; MARKET DRIVERS; A Tool for Speedy Accomplishment of Biochemical, Genetic, or Pharmacological Tests; Demand in Academia; The Combination of HTS and uHTS Has a Lot of Advantages; HTS Increases Cost-Effectiveness and Productivity; Others; MICROSPHERE ANALYSIS; ASSAY REAGENTS (MICROSPHERE); MULTIPLEX ASSAY SYSTEM/FLUORESCENCE MULTIPLEX ARRAYS; MICROSPHERES AND ASSAY KITS; MS; MARKET DRIVERS; Simple Quantification of Protein Structures Generates the Need for MS; MS Acts as a Supporting Element for Growing Technologies; Gaining Popularity of Hybrid MS Instruments is Boosting the Growth for MS; MARKET INHIBITORS; MS Fails to Analyze Small Quantities of Proteins; Manual Interruption Necessary, Increasing the Error Rate; TOP PLAYERS; IONIZATION SOURCES; MALDI; ESI; Atmospheric Pressure Chemical Ionization (APCI); MASS ANALYZERS; OTHERS; REAGENTS AND ANTIBODIES; AUTOMATED LIQUID HANDLING WORKSTATIONS; SPOT PICKERS; TOP PLAYERS; RECENT DEVELOPMENTS; Agreements and Collaborations (December 8, 2008); CHROMATOGRAPHY SYSTEMS; MARKET DRIVERS; LC/MS SYSTEMS; TOP PLAYERS; HPLC SYSTEMS; ION CHROMATOGRAPHY SYSTEMS; Market Drivers; Reduces the Analysis Time Leading to Higher Efficiency; Higher Sensitivity Ensuring Higher Accuracy Levels; Simultaneous Detection of Numerous Samples; NANOSCALE HPLC SYSTEMS; GC/MS SYSTEMS; TOP PLAYERS; COMPLETE PROTEIN PURIFICATION SYSTEMS; Market Drivers; User Friendly; Speedy and Suitable Start to All Purification; GEL PERMEATION CHROMATOGRPAHY SYSTEMS; COMPLETE LC-NMR-MSN SYSTEMS; Market Drivers; CHROMATOGRAPHY SYSTEM ACCESSORIES; Market Drivers; SUPERCRITICAL FLUID CHROMATOGRAPHY AND EXTRACTION SYSTEMS; CAPILLARY LC SYSTEMS; AUTOMATED SPE SYSTEMS; Market Growth; These Systems Are Good Platforms for Direct Injections of Plasma, Urine, Vegetable Oils, and Surface Water; These Systems Automate Cleaning of Sample and Analyte Enrichment; These Systems Eliminate Traditional Manual Sample Steps, Making Them Inexpensive Platforms for Speedy Analysis; Other Driving Factors; Need for Human Intervention Absorbs Enormous Time
CHAPTER FIVE: PROTEOMICS TECHNOLOGY MARKET: BASED ON TYPES; STRUCTURAL PROTEOMICS; X-Ray Crystallography; Market Drivers; Application in Drug Discovery Boosting Market Growth; Simple and Low Cost Solution Increasing Adoption Rates; Aids Effective Analysis in Short Span of Time; Top Players; Recent Developments; March 27, 2008 Agreements and Collaborations; NMR Spectroscopy; EXPRESSIONAL PROTEOMICS; Serial Analysis of Gene Expression (SAGE); DNA Chips; Top Players; BASED ON PROCESS; PROTEIN, IDENTIFICATION, SEQUENCING, AND CHARACTERIZATION; Top Players; TANDEM MASS SPETROMETRY (TD/MS); CIRCULAR DICHROISM (CD); SAMPLE PREPARATION; Top Players; Recent Developments; April 23, 2009: New Product Launch; CE SYSTEMS; PRESSURE CYCLING TECHNOLOGY
CHAPTER SIX: PROTEOMICS SERVICES MARKET: ANALYTICAL LABORATORY SERVICES; QUALITY CONTROL OF PROTEINS AND PROTEIN IDENTIFICATION; PROTEIN SEPARATION SERVICES; PROTEIN SEQUENCING SERVICE; DATA ANALYSIS AND MAINTENANCE; Top Players; DOCUMENT ANALYSIS AND DATA MINING SERVICES; Top Players; Recent Developments; April 7, 2009 Agreements and Collaborations
CHAPTER SEVEN: PROTEOMICS DATABASE AND SOFTWARE MARKET: PROTEOMICS SOFTWARE; OPPORTUNITIES; Proteomics Software Vendors’ Interest is Opening New Opportunities for This Market; Association with Academics Labs for Progression In Proteomics Software Ensures Growth In Near Future; Collaborations of Proteomics Software Providers with Institutes Open Up New Opportunities; MARKET DRIVERS; Proteomics Software Aids in Dynamic Analysis with Higher Throughput; Identifying Low Abundance Proteins; Detecting Post-Translational Modifications; Use of Proteomics Software Leads to Better Quantitation of Proteomics Data; Implementation and Integration of This Software Need the Attention of Experienced Personnel, which Demands Time and Resources; MS SOFTWARE; Top Players; PROTEIN VALIDATION AND QUANTIFICATION TECHNOLOGIES; MICROARRAY SOFTWARE; MF CHIP INSTRUMENT SOFTWARE; PROTEIN STRUCTURAL ANALYSIS; TANDEM MASS SPEC PROTEOMICS DATA VIEWER; PRIMER ANALYSIS; PROTEIN AND PEPTIDE IDENTIFICATION SOFTWARE; PROTEIN SEQUENCE AND PLASMID DRAWING ANALYSIS; GEL IMAGE ANALYSIS SOFTWARE; PROTEOMICS DATABASES; PROTEIN-PROTEIN INTERACTION; Top Players; PROTEIN SEQUENCE DATABASE; Top Players; Recent Development; April 3, 2009: New Technology Launch; PROTEINS AND GENES; GENE ONTOLOGY; 3-D STRUCTURES OF PROTEIN; GENERAL INFORMATION DATABASES; Top Players; GENERAL LABORATORY SOFTWARE PROGRAMS; DESKTOP DATABASE, MANAGEMENT PROGRAMS, AND OPERATING SYSTEMS; IMAGE PROCESSING AND ANALYSIS SOFTWARE PROGRAM; GRAPHING SOFTWARE PROGRAM
CHAPTER EIGHT: PROTEOMICS APPLICATIONS MARKET: DRUG DISCOVERY; MARKET DRIVERS; Shortcomings of Gene-Based Drug Discovery Igniting Adoption of Proteomics; Benefits Derived through Protein-Based Drug Design and Discovery Are Expected to Be the Key Factor Contributing to Growth of Proteomics in the Drug Discovery Market; Need to Understand the Dynamics of Protein Element; Continuous Search for Alternative and Efficient Methods to Deliver Enhanced Drugs; Increasing R&D Investments from Pharmaceutical and Biotech Companies; Potential Market in Growing Economies; Emerging Approaches and Innovations in Proteomics Improving Decision Support Tools; MARKET INHIBITORS; Lack of Enhanced Computational Tools Limiting the Scope of Effective Analysis; Limited Drug Alternatives Restricting the Scope of Proteomics; Prevailing Skepticism on the Feasibility of Manufacturing Protein-Based Drugs on Larger Levels, Impairing the Adoption of Proteomics; Limited Utility of Proteomics Due to Complexity Involved and Lack of Adequately Trained Manpower; DRUG DEVELOPMENT; DRUG TARGET VALIDATION; MARKET DRIVERS; Advantages of Target-Based Drug Discovery Leading to Profuse Investment from Drug Development Companies; Application of Proteomics Enabling Process Efficiency; Limited Knowledge on Protein Dynamics Limits High-Level Application; ADME-TOX Profiling; Target Identification; DIAGNOSIS MARKET; MARKET DRIVERS; Better Analysis of Kidney Diseases by Proteomics Supports Its Growth in Clinical Application; Determination of Protein Expression for Normal and Diseased States Spurs the Use of Proteomics as a Diagnostic Tool; Continuous Advancements in the Proteomics Technologies; MARKET INHIBITORS; Complexity of Proteomes Acts as a Barrier for the Use of Proteomics in Diagnostic Applications; Inability of Proteomic Diagnostic Tools to Give Accurate and Reproducible Results Slows Down Its Growth; NEW BIOMARKER; Market Drivers; High-Quality Proteomics Equipment Have Effectively Helped in Biomarker Detection in Complex Mixtures; Biomarker Detection for Excessive Alcohol Consumption is becoming a Popular Area for Proteomics; Market Inhibitors; Inability to Detect Some Important Biomarkers by Proteomics Tools Restricts Its Adoption in New Biomarker Application; A High Cost and Time Requirement for Biomarker Detection by Proteomics Experiments Confines the Use of Proteomics; PROTEIN-PROTEIN INTERACTION; PROTEIN QUANTIFICATION; PROTEIN PURIFICATION; PROTEIN IDENTIFICATION; GLOBAL THERAPY AND OTHERS MARKET; THERAPY; Market Drivers; Proteomics Application in Anesthesiology is Evolving as a New Area in Therapy; Proteomics Is Gaining Popularity as a Cancer Diagnostic Tool; Market Inhibitors; Proteomics-Based Therapy Market Still Not an Established Segment; Cost of Therapy Limiting the Scope; FOOD AND NUTRITION; HOMELAND SECURITY
CHAPTER NINE: GEOGRAPHIC ANALYSIS OF PROTEOMICS MARKET: NORTH AMERICA; EUROPE; ASIA; ROW
CHAPTER TEN: COMPANY PROFILES: 20/20 GENESYSTEMS, INC.; STRATEGY; ACTIVX BIOSCIENCES, INC.; STRATEGY; AGILENT TECHNOLOGIES; STRATEGY; AMGEN, INC.; STRATEGY; ANASPEC, INC; STRATEGY; APPLIED BIOSYSTEMS INC.; STRATEGY; ASTERAND, PLC; STRATEGY; BAYER TECHNOLOGY SERVICES; STRATEGY; BECKMAN COULTER, INC; STRATEGY; BECTON, DICKINSON, AND COMPANY (BD); STRATEGY; BG MEDICINE; STRATEGY; BIACORE INTERNATIONAL AB; BIOCARTA, INC; BIO-RAD LABORATORIES, INC.; STRATEGY; BRUKER BIOSCIENCES CORP.; STRATEGY; CALIPER LIFE SCIENCES INC; STRATEGY; CAPRION PROTEOMICS, INC.; STRATEGY; CELLZOME AG; STRATEGY; COMMONWEALTH BIOTECHNOLOGIES, INC.; STRATEGY; DIGILAB BIOVISION GMBH; STRATEGY; DIONEX CORP.; STRATEGY; DUALSYSTEMS BIOTECH AG; STRATEGY; DYAX CORP; STRATEGY; EPROGEN; STRATEGY; ERAGEN BIOSCIENCES; STRATEGY; EUROGENTEC; STRATEGY; GE HEALTHCARE; STRATEGY; GENEART GMBH; STRATEGY; GENEDATA AG; STRATEGY; GENENTECH, INC.; STRATEGY; INTRINSIC BIOPROBES, INC; STRATEGY; LIFESPAN BIOSCIENCES, INC; STRATEGY; MATRITECH, INC; STRATEGY; MATRIX SCIENCE, LTD.; STRATEGY; MDS, INC.; STRATEGY; MONARCH LIFESCIENCES; STRATEGY; NEXTGEN SCIENCES, LTD.; STRATEGY; NONLINEAR DYNAMICS, LTD.; STRATEGY; THERMO SCIENTIFIC OWL SEPARATION SYSTEMS; STRATEGY; PERKINELMER, INC.; STRATEGY; PROLEXYS PHARMACEUTICALS, INC.; STRATEGY; PROTAGEN AG; STRATEGY; PROTEA BIOSCIENCES, INC.; STRATEGY; TYRIAN DIAGNOSTICS; STRATEGY; SHIMADZU BIOTECH; STRATEGY; SOMALOGIC, INC. (USA); STRATEGY; SYNGENE; THERMO FISHER SCIENTIFIC, INC; STRATEGY; VBC-GENOMICS BIOSCIENCE RESEARCH GMBH (AUSTRIA); STRATEGY; XENCOR, INC; APPENDIX ONE; PROTEOMIC TECHNOLOGY PATENTS FOR THE U.S., EUROPE AND JAPAN; APPENDIX TWO; LIST OF ACRONYMS; LIST OF ACRONYMS (CONTINUED); LIST OF ACRONYMS (CONTINUED)
LIST OF TABLES: SUMMARY TABLE GLOBAL PROTEOMICS MARKET BY EQUIPMENT,; DATABASE AND SOFTWARE, TECHNOLOGY, AND SERVICES,; THROUGH 2014 ($ MILLIONS); TABLE 1 GLOBAL PROTEOMICS EQUIPMENT MARKET BY PRODUCT,; THROUGH 2014 ($ MILLIONS); TABLE 2 GLOBAL PROTEOMICS EQUIPMENT MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS); TABLE 3 GLOBAL PROTEIN CHIPS AND MICROARRAYS MARKET BY; PRODUCT, THROUGH 2014 ($ MILLIONS); TABLE 4 GLOBAL PROTEIN CHIPS AND MICROARRAYS MARKET,; THROUGH 2014 ($ MILLIONS); TABLE 5 RECENT DEVELOPMENTS; TABLE 6 GLOBAL BIO CHIPS/SLIDES MARKET BY GEOGRAPHIC; REGION, THROUGH 2014 ($ MILLIONS); TABLE 7 GLOBAL MICROARRAYS MARKET BY PRODUCT, THROUGH; 2014 ($ MILLIONS); TABLE 8 GLOBAL MICROARRAYS MARKET BY GEOGRAPHIC; REGION, THROUGH 2014 ($ MILLIONS); TABLE 9 GLOBAL SCANNERS MARKET BY GEOGRAPHIC REGION,; THROUGH 2014 ($ THOUSANDS); TABLE 10 GLOBAL INTEGRATED SYSTEMS MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS); TABLE 11 GLOBAL PROTEIN ANALYSIS SYSTEM/PROTEOMICS; SYSTEM MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS); TABLE 12 GLOBAL PROTEIN ANALYSIS SYSTEM/PROTEOMICS; SYSTEM MARKET BY GEOGRAPHIC REGION, THROUGH 2014; ($ MILLIONS); TABLE 13 GLOBAL PROTEIN-PROTEIN INTERACTION/AFFINITY; CHARACTERIZATION MARKET BY GEOGRAPHIC REGION,; THROUGH 2014 ($ MILLIONS); TABLE 14 GLOBAL MEMBRANE PROTEIN ANALYSIS SYSTEMS; MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS); TABLE 15 GLOBAL PROTEIN INTERACTION MONITORING SYSTEMS; REAGENTS MARKET BY GEOGRAPHIC REGION, THROUGH 2014; ($ THOUSANDS); TABLE 16 GLOBAL PROTEIN FRACTIONATION SYSTEM MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS); TABLE 17 GLOBAL SPR SYSTEM MARKET BY GEOGRAPHIC REGION,; THROUGH 2014 ($ THOUSANDS); TABLE 18 GLOBAL 2-DE MARKET BY PRODUCT, THROUGH 2014; ($ MILLIONS); TABLE 19 GLOBAL 2-DE MARKET BY GEOGRAPHIC REGION,; THROUGH 2014 ($ MILLIONS); TABLE 20 GLOBAL 2-DGE SYSTEMS MARKET BY GEOGRAPHIC; REGION, THROUGH 2014 ($ MILLIONS); TABLE 21 GLOBAL ISOELECTRIC FOCUSING SYSTEMS; (FRACTIONATORS, GELS, AND STRIPS) MARKET BY GEOGRAPHIC; REGION, THROUGH 2014 ($ THOUSANDS); TABLE 22 GLOBAL 2-DE CELLS MARKET BY GEOGRAPHIC REGION,; THROUGH 2014 ($ THOUSANDS); TABLE 23 GLOBAL 2-D PROTEIN MW MARKERS MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS); TABLE 24 GLOBAL MF CHIP TECHNOLOGY/MF SYSTEM MARKET BY; PRODUCT, THROUGH 2014 ($ MILLIONS); TABLE 25 GLOBAL MF CHIP TECHNOLOGY/MF SYSTEM MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS); TABLE 26 RECENT DEVELOPMENTS; TABLE 27 GLOBAL MF CHIPS AND CHIP-BASED IMMUNOASSAYS; MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS); TABLE 28 GLOBAL HTS MARKET BY GEOGRAPHIC REGION,; THROUGH 2014 ($ THOUSANDS); TABLE 29 GLOBAL MICROSPHERE ANALYSIS MARKET BY PRODUCT,; THROUGH 2014 ($ MILLIONS); TABLE 30 GLOBAL MICROSPHERE ANALYSIS MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS); TABLE 31 GLOBAL FLUORESCENT MICROSPHERE ASSAY AND; REAGENT MARKET BY GEOGRAPHIC REGION, THROUGH 2014; ($ THOUSANDS); TABLE 32 GLOBAL MULTIPLEX ASSAY SYSTEMS/FLUORESCENCE; MULTIPLEX ARRAYS MARKET BY GEOGRAPHIC REGION,; THROUGH 2014 ($ THOUSANDS); TABLE 33 GLOBAL MICROSPHERES AND ASSAY KITS MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS); TABLE 34 GLOBAL MS MARKET BY PRODUCT, THROUGH 2014; ($ MILLIONS); TABLE 35 GLOBAL MS MARKET BY GEOGRAPHIC REGION,; THROUGH 2014 ($ MILLIONS); TABLE 36 RECENT DEVELOPMENTS; TABLE 37 GLOBAL IONIZATION SOURCES MARKET BY PRODUCT,; THROUGH 2014 ($ MILLIONS); TABLE 38 GLOBAL IONIZATION SOURCES MARKET BY GEOGRAPHIC; REGION, THROUGH 2014 ($ MILLIONS); TABLE 39 GLOBAL MALDI MARKET BY GEOGRAPHIC REGION,; THROUGH 2014 ($ THOUSANDS); TABLE 40 GLOBAL ESI MARKET BY GEOGRAPHIC REGION,; THROUGH 2014 ($ THOUSANDS); TABLE 41 GLOBAL APCI MARKET BY GEOGRAPHIC REGION,; THROUGH 2014 ($ THOUSANDS); TABLE 42 GLOBAL MASS ANALYZERS MARKET BY GEOGRAPHIC; REGION, THROUGH 2014 ($ THOUSANDS); TABLE 43 GLOBAL OTHER EQUIPMENT MARKET BY PRODUCT,; THROUGH 2014 ($ MILLIONS); TABLE 44 GLOBAL OTHER EQUIPMENT MARKET BY GEOGRAPHIC; REGION, THROUGH 2014 ($ MILLIONS); TABLE 45 GLOBAL REAGENT AND ANTIBODIES MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS); TABLE 46 GLOBAL AUTOMATED LIQUID HANDLING WORKSTATIONS; MARKET BY GEOGRAPHIC REGION, THROUGH 2014; ($ THOUSANDS); TABLE 47 GLOBAL SPOT PICKERS MARKET BY GEOGRAPHIC; REGION, THROUGH 2014 ($ THOUSANDS); TABLE 48 GLOBAL CHROMATOGRAPHY SYSTEMS MARKET BY; PRODUCT, THROUGH 2014 ($ MILLIONS); TABLE 49 GLOBAL CHROMATOGRAPHY SYSTEMS MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS); TABLE 50 GLOBAL LC/MS SYSTEMS MARKET BY GEOGRAPHIC; REGION, THROUGH 2014 ($ THOUSANDS); TABLE 51 RECENT DEVELOPMENTS; TABLE 52 GLOBAL HPLC SYSTEMS MARKET BY PRODUCT,; THROUGH 2014 ($ MILLIONS); TABLE 53 GLOBAL HPLC SYSTEMS MARKET BY GEOGRAPHIC; REGION, THROUGH 2014 ($ THOUSANDS); TABLE 54 GLOBAL ION CHROMATOGRAPHY SYSTEMS MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS); TABLE 55 GLOBAL NANOSCALE HPLC SYSTEMS MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS); TABLE 56 GLOBAL GC/MS SYSTEMS MARKET BY GEOGRAPHIC; REGION, THROUGH 2014 ($ THOUSANDS); TABLE 57 NEW PRODUCT DEVELOPMENT; TABLE 58 GLOBAL COMPLETE PROTEIN PURIFICATION SYSTEMS; MARKET BY GEOGRAPHIC REGION, THROUGH 2014; ($ THOUSANDS); TABLE 59 GLOBAL GEL PERMEATION CHROMATOGRAPHY SYSTEMS; MARKET BY GEOGRAPHIC REGION, THROUGH 2014; ($ THOUSANDS); TABLE 60 GLOBAL COMPLETE LC-NMR-MSN SYSTEMS MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS); TABLE 61 GLOBAL CHROMATOGRAPHY SYSTEM ACCESSORIES; MARKET BY GEOGRAPHIC REGION, THROUGH 2014; ($ THOUSANDS); TABLE 62 GLOBAL SUPERCRITICAL FLUID CHROMATOGRAPHY AND; EXTRACTION MARKET BY GEOGRAPHIC REGION, THROUGH 2014; ($ THOUSANDS); TABLE 63 GLOBAL CAPILLARY LC SYSTEMS MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS); TABLE 64 GLOBAL AUTOMATED SPE SYSTEMS MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS); TABLE 65 GLOBAL PROTEOMICS TECHNOLOGY MARKET BY; PRODUCT, THROUGH 2014 ($ MILLIONS); TABLE 66 GLOBAL PROTEOMICS TECHNOLOGY MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS); TABLE 67 GLOBAL PROTEOMICS TECHNOLOGY MARKET BASED ON; PRODUCT TYPES, THROUGH 2014 ($ MILLIONS); TABLE 68 GLOBAL PROTEOMICS TECHNOLOGY MARKET BASED ON; TYPES BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS); TABLE 69 GLOBAL STRUCTURAL PROTEOMICS MARKET BY; PRODUCT, THROUGH 2014 ($ MILLIONS); TABLE 70 GLOBAL STRUCTURAL PROTEOMICS MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS); TABLE 71 GLOBAL X-RAY CRYSTALLOGRAPHY MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS); TABLE 72 ACQUISITION/MERGERS/JOINT VENTURES; TABLE 73 GLOBAL NMR SPECTROSCOPY MARKET BY GEOGRAPHIC; REGION, THROUGH 2014 ($ MILLIONS); TABLE 74 GLOBAL EXPRESSIONAL PROTEOMICS MARKET BY; PRODUCT, THROUGH 2014 ($ MILLIONS); TABLE 75 GLOBAL EXPRESSIONAL PROTEOMICS MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS); TABLE 76 GLOBAL SAGE MARKET BY GEOGRAPHIC REGION,; THROUGH 2014 ($ THOUSANDS); TABLE 77 GLOBAL DNA CHIPS MARKET BY GEOGRAPHIC REGION,; THROUGH 2014 ($ THOUSANDS); TABLE 78 RECENT DEVELOPMENT; TABLE 79 GLOBAL PROTEOMICS TECHNOLOGY BASED ON PROCESS; MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS); TABLE 80 GLOBAL PROTEOMICS TECHNOLOGY BASED ON PROCESS; MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS); TABLE 81 GLOBAL PROTEIN, IDENTIFICATION, SEQUENCING, AND; CHARACTERIZATION MARKET BY PRODUCT, THROUGH 2014; ($ MILLIONS); TABLE 82 GLOBAL PROTEIN, IDENTIFICATION, SEQUENCING, AND; CHARACTERIZATION MARKET BY GEOGRAPHIC REGION,; THROUGH 2014 ($ MILLIONS); TABLE 83 RECENT DEVELOPMENT; TABLE 84 GLOBAL TANDEM MS MARKET BY GEOGRAPHIC REGION,; THROUGH 2014 ($ THOUSANDS); TABLE 85 GLOBAL CD MARKET BY GEOGRAPHIC REGION, THROUGH; 2014 ($ THOUSANDS); TABLE 86 GLOBAL SAMPLE PREPARATION MARKET BY PRODUCT,; THROUGH 2014 ($ THOUSANDS); TABLE 87 GLOBAL SAMPLE PREPARATION MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS); TABLE 88 GLOBAL CE SYSTEMS MARKET BY GEOGRAPHIC REGION,; THROUGH 2014 ($ THOUSANDS); TABLE 89 GLOBAL PRESSURE CYCLING TECHNOLOGY MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS); TABLE 90 GLOBAL PROTEOMICS SERVICES MARKET BY PRODUCT,; THROUGH 2014 ($ MILLIONS); TABLE 91 GLOBAL PROTEOMICS SERVICES MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS); TABLE 92 GLOBAL ANALYTICAL LABORATORY SERVICES MARKET; BY PRODUCT, THROUGH 2014 ($ MILLIONS); TABLE 93 GLOBAL ANALYTICAL LABORATORY SERVICES MARKET; BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS); TABLE 94 GLOBAL DATA ANALYSIS AND MAINTENANCE MARKET; BY PRODUCT, THROUGH 2014 ($ THOUSANDS); TABLE 95 GLOBAL DATA ANALYSIS AND MAINTENANCE MARKET; BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS); TABLE 96 GLOBAL BIOINFORMATICS AND COMPUTATIONAL; PROTEOMICS MARKET BY GEOGRAPHIC REGION, THROUGH 2014; ($ THOUSANDS); TABLE 97 RECENT DEVELOPMENTS; TABLE 98 GLOBAL DOCUMENT ANALYSIS AND DATA MINING; SERVICES MARKET BY GEOGRAPHIC REGION, THROUGH 2014; ($ THOUSANDS); TABLE 99 GLOBAL PROTEOMICS DATABASE AND SOFTWARE; MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS); TABLE 100 GLOBAL PROTEOMICS DATABASE AND SOFTWARE; MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS); TABLE 101 GLOBAL PROTEOMICS SOFTWARE MARKET BY; PRODUCT, THROUGH 2014 ($ MILLIONS); TABLE 102 GLOBAL PROTEOMICS SOFTWARE MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS); TABLE 103 GLOBAL MS SOFTWARE MARKET BY GEOGRAPHIC; REGION, THROUGH 2014 ($ THOUSANDS); TABLE 104 GLOBAL PROTEIN VALIDATION AND QUANTIFICATION; TECHNOLOGIES MARKET BY GEOGRAPHIC REGION, THROUGH; 2014 ($ THOUSANDS); TABLE 105 GLOBAL MICROARRAY SOFTWARE MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS); TABLE 106 GLOBAL MF CHIP INSTRUMENT SOFTWARE MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS); TABLE 107 GLOBAL PROTEIN STRUCTURAL ANALYSIS MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS); TABLE 108 GLOBAL TANDEM MASS SPEC PROTEOMICS DATA; VIEWER MARKET BY GEOGRAPHIC REGION, THROUGH 2014; ($ THOUSANDS); TABLE 109 GLOBAL PRIMER ANALYSIS MARKET BY GEOGRAPHIC; REGION, THROUGH 2014 ($ THOUSANDS); TABLE 110 GLOBAL PROTEIN AND PEPTIDE IDENTIFICATION; SOFTWARE MARKET BY GEOGRAPHIC REGION, THROUGH 2014; ($ THOUSANDS); TABLE 111 GLOBAL PROTEIN SEQUENCE AND PLASMID DRAWING; ANALYSIS MARKET BY GEOGRAPHIC REGION, THROUGH 2014; ($ THOUSANDS); TABLE 112 GLOBAL GEL IMAGE ANALYSIS SOFTWARE MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS); TABLE 113 GLOBAL PROTEOMICS DATABASES MARKET BY; PRODUCT, THROUGH 2014 ($ MILLIONS); TABLE 114 GLOBAL PROTEOMICS DATABASES MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS); TABLE 115 GLOBAL PROTEIN-PROTEIN INTERACTION MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS); TABLE 116 RECENT DEVELOPMENTS; TABLE 117 GLOBAL PROTEIN SEQUENCE DATABASE MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS); TABLE 118 GLOBAL PROTEINS AND GENES MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS); TABLE 119 GLOBAL GENE ONTOLOGY MARKET BY GEOGRAPHIC; REGION, THROUGH 2014 ($ THOUSANDS); TABLE 120 GLOBAL 3-D STRUCTURES OF PROTEIN MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS); TABLE 121 RECENT DEVELOPMENT; TABLE 122 GLOBAL GENERAL INFORMATION DATABASE MARKET; BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS); TABLE 123 RECENT DEVELOPMENTS; TABLE 124 GLOBAL GENERAL LABORATORY SOFTWARE PROGRAMS; MARKET BY PRODUCT, THROUGH 2014 ($ THOUSANDS); TABLE 125 GLOBAL GENERAL LABORATORY SOFTWARE PROGRAMS; MARKET BY GEOGRAPHIC REGION, THROUGH 2014; ($THOUSANDS); TABLE 126 GLOBAL DESKTOP DATABASE, MANAGEMENT; PROGRAMS, AND OPERATING SYSTEMS MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS); TABLE 127 GLOBAL IMAGE PROCESSING AND ANALYSIS SOFTWARE; PROGRAM MARKET BY GEOGRAPHIC REGION, THROUGH 2014; ($ THOUSANDS); TABLE 128 GLOBAL GRAPHING SOFTWARE PROGRAM MARKET BY; GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS); TABLE 129 GLOBAL PROTEOMICS APPLICATIONS MARKET; THROUGH 2014 ($ MILLIONS); TABLE 130 GLOBAL DRUG DISCOVERY APPLICATIONS MARKET BY; PRODUCT, THROUGH 2014 ($ MILLIONS); TABLE 131 GLOBAL DIAGNOSIS APPLICATIONS MARKET BY; PRODUCT, THROUGH 2014 ($ MILLIONS); TABLE 132 GLOBAL THERAPY AND OTHERS APPLICATIONS MARKET; BY PRODUCT, THROUGH 2014 ($ MILLIONS); TABLE 133 NORTH AMERICAN PROTEOMICS MARKET BY SEGMENT,; THROUGH 2014 ($ MILLIONS); TABLE 134 EUROPEAN PROTEOMICS MARKET BY SEGMENT,; THROUGH 2014 ($ MILLIONS); TABLE 135 ASIAN PROTEOMICS MARKET BY SEGMENT, THROUGH; 2014 ($ MILLIONS); TABLE 136 ROW PROTEOMICS MARKET BY SEGMENT, THROUGH; 2014 ($ MILLIONS); TABLE 137 20/20 GENESYSTEMS, INC. PRODUCT PORTFOLIO; TABLE 138 ACTIVX BIOSCIENCES, INC. PRODUCT; PORTFOLIO; TABLE 139 AGILENT TECHNOLOGIES PRODUCT PORTFOLIO; TABLE 140 AGILENT TECHNOLOGIES STRATEGY; TABLE 141 AMGEN, INC. PRODUCT PORTFOLIO; TABLE 142 ANASPEC, INC. PRODUCT PORTFOLIO; TABLE 143 ANASPEC, INC. STRATEGY; TABLE 144 APPLIED BIOSYSTEMS INC. PRODUCT PORTFOLIO; TABLE 145 APPLIED BIOSYSTEMS INC. STRATEGY; TABLE 146 ASTERAND, PLC PRODUCT PORTFOLIO; TABLE 147 ASTERAND, PLC STRATEGY; TABLE 148 BAYER TECHNOLOGY SERVICES PRODUCT PORTFOLIO; TABLE 149 BECKMAN COULTER, INC. PRODUCT PORTFOLIO; TABLE 150 BD PRODUCT PORTFOLIO; TABLE 151 BG MEDICINE PRODUCT PORTFOLIO; TABLE 152 BG MEDICINE STRATEGY; TABLE 153 BIACORE INTERNATIONAL AB PRODUCT PORTFOLIO; TABLE 154 BIOCARTA, INC. PRODUCT PORTFOLIO; TABLE 155 BIO-RAD LABORATORIES, INC. PRODUCT PORTFOLIO; TABLE 156 BIO-RAD LABORATORIES, INC. STRATEGY; TABLE 157 BRUKER BIOSCIENCES CORPORATION PRODUCT; PORTFOLIO; TABLE 158 CALIPER LIFE SCIENCES INC. PRODUCT PORTFOLIO; TABLE 159 CALIPER LIFE SCIENCES, INC. STRATEGY; TABLE 160 CAPRION PROTEOMICS, INC. PRODUCT PORTFOLIO; TABLE 161 CELLZOME AG PRODUCT PORTFOLIO; TABLE 162 COMMONWEALTH BIOTECHNOLOGIES, INC. PRODUCT; PORTFOLIO; TABLE 163 DIGILAB BIOVISION GMBH PRODUCT PORTFOLIO; TABLE 164 DIGILAB BIOVISION GMBH STRATEGY; TABLE 165 DIONEX CORP. PRODUCT PORTFOLIO; TABLE 166 DIONEX CORP. STRATEGY; TABLE 167 DUALSYSTEMS BIOTECH AG PRODUCT PORTFOLIO; TABLE 168 DYAX CORP. PRODUCT PORTFOLIO; TABLE 169 EPROGEN PRODUCT PORTFOLIO; TABLE 170 ERAGEN BIOSCIENCES PRODUCT PORTFOLIO; TABLE 171 EUROGENTEC PRODUCT PORTFOLIO; TABLE 172 GE HEALTHCARE PRODUCT PORTFOLIO; TABLE 173 GENEART GMBH PRODUCT PORTFOLIO; TABLE 174 GENEDATA AG PRODUCT PORTFOLIO; TABLE 175 GENEDATA AG STRATEGY; TABLE 176 GENENTECH INC. PRODUCT PORTFOLIO; TABLE 177 GENENTECH INC. STRATEGY; TABLE 178 INTRINSIC BIOPROBES, INC. PRODUCT PORTFOLIO; TABLE 179 LIFESPAN BIOSCIENCES, INC. PRODUCT PORTFOLIO; TABLE 180 MATRITECH, INC. PRODUCT PORTFOLIO; TABLE 181 MATRIX SCIENCE, LTD. PRODUCT PORTFOLIO; TABLE 182 MDS INC. PRODUCT PORTFOLIO; TABLE 183 MONARCH LIFESCIENCES PRODUCT PORTFOLIO; TABLE 184 NEXTGEN SCIENCES, LTD. PRODUCT PORTFOLIO; TABLE 185 NONLINEAR DYNAMICS, LTD. PRODUCT PORTFOLIO; TABLE 186 NONLINEAR DYNAMICS, LTD. STRATEGY; TABLE 187 THERMO SCIENTIFIC OWL SEPARATION SYSTEMS; PRODUCT PORTFOLIO; TABLE 188 PERKINELMER, INC PRODUCT PORTFOLIO; TABLE 189 PERKINELMER, INC. STRATEGY; TABLE 190 PROLEXYS PHARMACEUTICALS, INC. PRODUCT; PORTFOLIO; TABLE 191 PROTAGEN AG PRODUCT PORTFOLIO; TABLE 192 PROTEA BIOSCIENCES, INC. (USA) PRODUCT PORTFOLIO; TABLE 193 PROTEA BIOSCIENCES, INC. (USA) STRATEGY; TABLE 194 TYRIAN DIAGNOSTICS PRODUCT PORTFOLIO; TABLE 195 SHIMADZU BIOTECH PRODUCT PORTFOLIO; TABLE 196 SOMALOGIC, INC. (USA) PRODUCT PORTFOLIO; TABLE 197 SYNGENE PRODUCT PORTFOLIO; TABLE 198 THERMO FISHER SCIENTIFIC INC. PRODUCT PORTFOLIO; TABLE 199 VBC-GENOMICS BIOSCIENCE RESEARCH GMBH; (AUSTRIA) PRODUCT PORTFOLIO; TABLE 200 XENCOR, INC. PRODUCT PORTFOLIO; TABLE 201 PROTEOMIC TECHNOLOGY PATENTS FOR THE U.S.,; EUROPE AND JAPAN
LIST OF FIGURES: SUMMARY FIGURE GLOBAL PROTEOMICS MARKET BY EQUIPMENT,; DATABASE AND SOFTWARE, TECHNOLOGY, AND SERVICES BY; SEGMENT, 2007-2014 ($ MILLIONS); FIGURE 1 EVOLUTION OF PROTEOMICS AND FUTURE TRANSITION; FIGURE 2 PROTEOMICS MARKET DEFINITION CHART; FIGURE 3 RELATIVE IMPORTANCE OF PROTEOMICS SYSTEMS AND; TECHNOLOGY ISSUES; FIGURE 4 BCG MATRIX FOR PROTEOMICS EQUIPMENT MARKET,; 2009; FIGURE 5 PATENT ANALYSIS BY TECHNOLOGY, 2006; FIGURE 6 PATENT ANALYSIS BY TECHNOLOGY, 2008; FIGURE 7 BCG MATRIX FOR PROTEOMICS SERVICE MARKET -; ANALYTICAL LABORATORY SERVICES, 2009; FIGURE 8 KEY MARKET FACTORS INFLUENCING THE GROWTH OF; PROTEOMICS; FIGURE 9 PATENT ANALYSIS BY ASSIGNEE, 2009* (%); FIGURE 10 CURRENT AND FUTURE POTENTIAL FOR PROTEOMICS; APPLICATION MARKET; FIGURE 11 SUPPLY SIDE STAKEHOLDER ANALYSIS, 2009; FIGURE 12 DEMAND SIDE STAKEHOLDER ANALYSIS, 2009

More Global Research & Development Reports

Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition by Kalorama Information
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, ...

Global Biotechnology by IBISWorld
Global Biotechnology Biotechnology is the application of science and technology to living organisms as well as parts, products and models thereof, to alter living or non-living ...

Global Protein Therapeutics Market Forecast to 2015 by RNCOS
Protein-based therapies have found a prominent place in the biopharmaceutical industry since the launch of human insulin product. They have become one of the most ...

Global Pharmaceuticals, Biotechnology & Life Sciences by MarketLine
Introduction Global Pharmaceuticals, Biotechnology & Life Sciences industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2006-10, and forecast to ...

Biotechnology by Global Industry Analysts
The global outlook series on Biotechnology provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings. The report offers a bird’s ...

See all reports like this >>

Proteomics: Technologies and Global Markets

Share this report

Other tasks

Research Assistance

Related Markets

Research & Development Reports

Free Alert Me service